The incorporation of ESCC-PS and expression of PD-L1 was performed based on the multivariate cox regression analyses to elucidate the incremental value of the ESCC-PS added to the expression of PD-L1 for predicting the outcome of PD-1 inhibitors. The gene discussed is CD274; the disease is esophageal squamous cell carcinoma.